Evidence map›Paper›PMID 22383528›Full record

ArticleThe Journal of biological chemistry2012

Neutral sphingomyelinase 2 deficiency increases hyaluronan synthesis by up-regulation of Hyaluronan synthase 2 through decreased ceramide production and activation of Akt.

Jingdong Qin, Evgeny Berdyshev, Christophe Poirer, Nancy B Schwartz, Glyn Dawson

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Disruption of adipocyte HIF-1Acta pharmaceutica Sinica. B · 2022
    Article
  5. Review
  6. Regulatory role of mammalian target of rapamycin signaling in exosome secretion and osteogenic changes in smooth muscle cells lacking acid ceramidase gene.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jingdong QinDepartment of Pediatrics, University of Chicago, Chicago, Illinois 60637, USA.
Evgeny Berdyshev
Christophe Poirer
Nancy B Schwartz
Glyn Dawson
University of Chicago · USUniversity of Illinois Chicago · US

Funding

GLYCOSPHINGOLIPID METABOLISM AND MENTAL RETARDATIONR01NS036866 · NINDS · UNIVERSITY OF CHICAGO · PI DAWSON, GLYN · 1997 to 2015
$4.4M
NINDS NIH HHS NS36866-37NINDS NIH HHS R01 NS036866
6 · The paper itself

Abstract

Fibroblasts from the fro/fro mouse, with a deletion in the Smpd3 gene coding for the active site of neutral sphingomyelinase 2 (NSMase2), secreted increased amounts of hyaluronan (HA). This was reversed by transfection with the Smpd3 gene, suggesting a connection between sphingolipid and glycosaminoglycan metabolism. The deficiency of NSMase2 resulted in storage of sphingomyelin (SM) and cholesterol with a 50% reduction in ceramides (Cer). RT-PCR and Western blot analysis showed that increased HA secretion resulted from increased hyaluronan synthase 2 (HAS2) activity localized to sphingolipid-enriched lipid rafts. Although cholesterol levels were also elevated in lipid rafts from mouse fibroblasts deficient in lysosomal acid SMase activity (deletion of the Smpd1(-/-) gene), there was no increase in HA secretion. We then showed that in fro/fro fibroblasts, the reduced ceramide was associated with decreased phosphorylation of protein phosphatase 2A (PP2A) and increased phosphorylation of its substrate Akt-p, together with PI3K, PDK1, mTOR (mammalian target of rapamycin), and p70S6K, although PTEN was unaffected. Exogenous ceramide, as well as inhibitors of Akt (Akt inhibitor VIII), PI 3-kinase (LY294002 and wortmannin), and mTOR (rapamycin) reduced secretion of HA, whereas the NSMase2 inhibitor GW4869 increased HA synthesis and secretion. We propose that NSMase2/Cer are the key mediators of the regulation of HA synthesis, via microdomains and the Akt/mTOR pathway.

Indexed as

AnimalsBrainCeramidesEnzyme ActivationFibroblastsGene Expression ProfilingGene Expression Regulation, EnzymologicGlucuronosyltransferaseGlycosaminoglycansHyaluronan SynthasesHyaluronic AcidMembrane MicrodomainsMiceOsteogenesis ImperfectaPhosphorylationProto-Oncogene Proteins c-aktCeramidesGlucuronosyltransferaseGlycosaminoglycansHas2 protein, mouseHyaluronan SynthasesHyaluronic AcidMTOR protein, humanProto-Oncogene Proteins c-aktSmpd3 protein, mouseSphingolipidsSphingomyelin PhosphodiesteraseTOR Serine-Threonine Kinases

Identifiers

PMID22383528
PMCPMC3340193
OpenAlexW2028228502

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.